Delivery Order SPE2DR25D1103-SPE2DR26FF127
Award Date 2/3/26
Potential Completion Date 2/4/26
Potential Value $4.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,260.61 to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of NURTEC ODT 75 MG tablets in quantities of 8 units. This firm fixed-price delivery order, which is scheduled for completion by January 26, 2026, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $79,324.76 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 17, 2025, with completion scheduled for November 18, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,163.59 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packages) on November 24, 2025, with completion expected by November 25, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency (DLA) awarded a $38,746.17 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 14, 2025, with completion expected by November 17, 2025. The contract utilized firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and performed the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,914.63 to AmerisourceBergen Drug Corp on February 3, 2026, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively sourced. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency (DLA) awarded a $11,492.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 3, 2026, for the supply of NURTEC ODT 75 MG tablets (8 units). This non-set-aside contract was competitively awarded and is scheduled for completion by February 4, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,588.27 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) under a firm fixed-price contract. This delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a competitively awarded, non-set-aside procurement for pharmaceutical products to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,961.09 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed-price, competitively awarded delivery order was executed on November 20, 2025, with an ultimate completion date of November 21, 2025. The contract represents a pharmaceutical supply delivery under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,257.66 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on January 12, 2026, with ultimate completion by January 13, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,429.25 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...